Log in
Enquire now
‌

US Patent 9605319 Gene signatures for cancer diagnosis and prognosis

Patent 9605319 was granted and assigned to Myriad Genetics on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Myriad Genetics
Myriad Genetics
0
Date Filed
August 30, 2011
0
Date of Patent
March 28, 2017
0
Patent Application Number
13819963
0
Patent Citations Received
‌
US Patent 12026683 System and method for risk assessment of a third party application for controlling competitive migration
0
Patent Inventor Names
Julia Reid
0
Susanne Wagner
0
Alexander Gutin
0
Steven Stone
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9605319
0
Patent Primary Examiner
‌
Joseph G. Dauner
0

Find more entities like US Patent 9605319 Gene signatures for cancer diagnosis and prognosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.